deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of He... ( REYKJAVIK Iceland Oct. 9 /- deCOD...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack

Date:10/9/2007

REYKJAVIK, Iceland, Oct. 9 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced that it has begun enrolling patients for its Phase IIa clinical trial for DG051, the company's leukotriene A4 hydrolase inhibitor being developed for the prevention of heart attack.

In Phase I studies completed earlier this year, DG051 significantly reduced the production of leukotriene B4 (LTB4) in a dose dependent manner. LTB4 is a pro-inflammatory molecule that deCODE's gene discovery and functional biology work identified as a key factor in modulating risk of heart attack. The Phase I studies showed DG051 to be safe and well-tolerated at all dose levels tested, with a favourable pharmacokinetic profile. DG051 was also recently evaluated in a 28-day Phase I study that further demonstrated that the drug can deliver significant, sustained reductions in LTB4 levels with once-daily dosing.

The design of the Phase IIa study is based upon these findings by studying the effect of DG051 in patients with a history of heart attack or coronary artery disease. The Phase IIa is a randomized, double-blind, placebo- controlled trial that will examine the impact of DG051 on the production of LTB4 as well as the compound's pharmacokinetic and safety and tolerability profiles in heart patients. The company will use the results from this study to inform dose selection for a larger Phase IIb trial planned to commence early next year.

"We are advancing DG051 as a novel means of preventing heart attack, the leading cause of death in the industrialized world. Our clinical studies thus far have shown that it effectively reins in the activity of a branch of the leukotriene pathway that has been linked to risk of heart attac
'/>"/>

SOURCE deCODE genetics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
2. deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis

Post Your Comments:

(Date:5/22/2013)... Calif. , May 22, 2013 Rigel ... the clinical advancement of three programs in development. The ... a JAK/SYK inhibitor, R348, being developed by Rigel as ... programs are aimed at oncology targets and are being ... under development by BerGenBio AS (BerGenBio) and a ligase ...

(Date:5/22/2013)... , May 22, 2013 Assured Pharmacy, Inc. ... prescription medications to sufferers of chronic pain, announced it ... national investor relations firm, to raise its visibility and ... "Over the past year, we have proven our business ... announced plans to open two additional new pharmacies in ...

(Date:5/22/2013)... WomanCare Global recently launched Simplant in ... training initiative attended by 90 health care providers. ... http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) Simplant, a long-acting ... subdermal implant composed of two thin, flexible, silicone ... form of the hormone progestin). These are inserted ...

Breaking Medicine Technology:Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2 Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3 Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4 Assured Pharmacy Hires Hayden IR 2 Assured Pharmacy Hires Hayden IR 3 WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile 2

[0] Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye [0] Assured Pharmacy Hires Hayden IR [0] WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile

... 7, 2011 Talyst announces AutoPharm® Mobile, an ... The mobile application can be conveniently accessed on ... efficiency and control across the health system. ... to have real-time access to medication inventory throughout ...

... NEW YORK, Dec. 7, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p098411/Global-Microscopes-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_I This report ... US$ Million by the following Product Segments: ...

Cached Medicine Technology:Talyst Releases AutoPharm Mobile 2 Global Microscopes Industry 2

Talyst Releases AutoPharm Mobile Global Microscopes Industry

(Date:5/21/2013)... Springs, CO (PRWEB) May 22, 2013 ... plan for better nutrition--from farmers' markets filled with whole ... consumers make the most of the season the nutrition ... a healthier lifestyle not to miss. , 1. Eating ... weather that invites shoppers to linger and explore, spring ...

(Date:5/21/2013)... May 21, 2013 Standard advice for ... and little else. However given industry’s less than exceptional ... shoppers via the internet, Consumer Mattress Reports sets out ... Choosing The Best Mattress .” , This article addresses ... and suggestions that may not be readily apparent to ...

(Date:5/21/2013)... Atlanta, GA (PRWEB) May 21, 2013 Patients ... Dental Care who have lost teeth due to gum disease ... traditional surgery for gum disease treatment with laser gum ... implants, which have the highest success rate out of all ... Procedure (LANAP) is a relatively new procedure cleared by the ...

(Date:5/21/2013)... 21, 2013) Prostaglandin analogues (PGAs), drugs which lower ... for people with glaucoma, but their use is not ... vision, dryness, changes in eye color and other side ... drugs also cause upper and lower eyelid drooping and ... are described in PLOS ONE . , Researchers ...

(Date:5/21/2013)... HealthSmart continues to grow through strategic acquisitions and ... hiring of new talent in several areas, including Account ... Dawn Powell has joined the organization effective April 28, ... Management in the Central Region and is based in ... client management, employee benefits, and product development experience, she ...

Breaking Medicine News(10 mins):Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2 Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3 Health News:Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article 2 Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2 Health News:Glaucoma drug can cause droopy eyelids 2 Health News:New Talent Joins the HealthSmart Account Management Team 2

[0] Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring [0] Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article [0] Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA [0] Glaucoma drug can cause droopy eyelids [0] New Talent Joins the HealthSmart Account Management Team

... of extensive surgery, researchers say , THURSDAY, Aug. 13 (HealthDay ... the extent of early breast cancer may do more harm ... said this use of MRI increases the likelihood that patients ... but that this more aggressive treatment doesn,t lead to improved ...

... , , , ... Inc. (NYSE Amex: KAD ), a leading provider of home care, ... for its fiscal first quarter ended June 30, 2009. , ... revenues of $26.4 million compared with $26.8 million for the same period last ...

... LOS ANGELES, Aug. 13 From cranky bosses to incompetent ... people encounter while making their way through the typical work day ... people up a wall. , , Tanna Marshall, ... 18 years, experience as a natural health practitioner, offers a collection ...

... ... the First in Georgia to Offer Online Records and Direct E-mail Access to Doctors, a ... ... affiliated with Northside Hospital, is leading the way as one of the first physicians’ offices ...

... NES ZIONA, Israel, August 13 Following the ... NanoPass,Technologies Ltd. (NanoPass) announced today that it has successfully,developed ... effectiveness and supply of pandemic flu vaccines. , ... 11th, 2009", said Dr Yotam Levin, the,Company,s CEO, "the ...

... , SEATTLE, Aug. 13 The ... been appointed to head its new European office in London, effective ... health policy and advocacy. , , "Expanding our ... we,re very pleased that Joe will be leading this effort," said ...

MRI May Not Improve Breast Cancer Outcome Arcadia Resources Announces First Quarter Results 'Living Peacefully in a Big City': Natural Health Practitioner Offers Advice on Maintaining Sanity, Health and Happiness Atlanta Women's Specialists Raises the Bar in Patient Care With Online Medical Records and an Electronic Medical Records System NanoPass Makes its MicronJet Technology Available to Increase Global Supply of Pandemic Influenza Vaccines Bill & Melinda Gates Foundation Appoints Joe Cerrell to Lead New European Office

... As part of our continued effort to standardize ... to introduce the new PowerPro® Electric II Handpiece ... single trigger handpiece, a dedicated oscillating saw, a ... to this system are features such as speed, ...

... power line from MicroAire. Our new ... electric instruments, offering the ultimate in ... has always wanted with the security ... Power Master oscillating saw, Available with ...

... Linvatec Advantage System is a full-function, ... electric handpieces for a wide range ... Bone Orthopedics, Small Bone Orthopedics, Orthopedic ... Neurosurgery, and Spine Surgery. Because it ...

... System consists of a pistol-grip handpiece available ... a wide range of couplers that can ... surgical applications., ,MicroAire SmartDriver. Modular Pistol-Grip ... with different module for drilling, pinning, cutting, ...

Medicine Products:

PowerPro® Electric II System Powermaster Oscillating Saw Advantage System Electric SmartDriver